U.S. markets close in 5 hours 20 minutes
  • S&P 500

    4,193.55
    +71.08 (+1.72%)
     
  • Dow 30

    33,270.51
    +496.10 (+1.51%)
     
  • Nasdaq

    12,766.24
    +272.31 (+2.18%)
     
  • Russell 2000

    1,949.85
    +36.96 (+1.93%)
     
  • Crude Oil

    88.37
    -2.13 (-2.35%)
     
  • Gold

    1,814.20
    +1.90 (+0.10%)
     
  • Silver

    20.74
    +0.26 (+1.26%)
     
  • EUR/USD

    1.0347
    +0.0129 (+1.26%)
     
  • 10-Yr Bond

    2.7170
    -0.0800 (-2.86%)
     
  • GBP/USD

    1.2248
    +0.0172 (+1.42%)
     
  • USD/JPY

    132.1220
    -2.9940 (-2.22%)
     
  • BTC-USD

    23,913.11
    +825.67 (+3.58%)
     
  • CMC Crypto 200

    562.33
    +31.11 (+5.86%)
     
  • FTSE 100

    7,498.20
    +10.05 (+0.13%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

EMERYVILLE, Calif., July 21, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the second quarter 2022 after market on Tuesday, August 9, 2022. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Berkeley Lights, Inc., logo (PRNewsfoto/Berkeley Lights)
Berkeley Lights, Inc., logo (PRNewsfoto/Berkeley Lights)

Live audio of the webcast will be available on the "Investors" section of the Company's website at www.berkeleylights.com. The webcast will be archived and available for replay after the event.

About Berkeley Lights

Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Forward-Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company's growth and continual evolution see the statements in the "Risk Factors" sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/berkeley-lights-to-report-second-quarter-2022-financial-results-on-august-9-2022-301591330.html

SOURCE Berkeley Lights, Inc.